2022 International Congress of Diabetes and Metabolism

Skip Navigation: Skip to contents

- Home
- Login

Corporate symposia

Plenary lectures Main Symposia Committee sessions Research group sessions Special sessions Sponsored sessions

Breakfast symposium 1 Sponsored by MSD	08:20~08:50 / Friday 7 October Grand Ballroom A, Hotel, 2F Chairman:Hyoungwoo Lee

Hwi Seung Kim Chung-Ang University, Korea	BS1How to find the optimal combination therapy for patients with type 2 diabetes

Breakfast symposium 2 Sponsored by Yuhan	08:20~08:50 / Friday 7 October Grand Ballroom B, Hotel, 2F Chairman:Soon Hee Lee

Clifford J. Bailey Aston University, UK	BS210 years of improvement in type 2 diabetes patient care

Breakfast symposium 3 Sponsored by Ildong Pharmaceutical	08:20~08:50 / Saturday 8 October Grand Ballroom A, Hotel, 2F Chairman:Kang Seo Park

Changhee Jung University of Ulsan, Korea	BS3Efficacy and safety of combination treatment with SGLT2 inhibitor and DPP4 inhibitor

Breakfast symposium 4 Sponsored by Sanofi Aventis	08:20~08:50 / Saturday 8 October Grand Ballroom B, Hotel, 2F Chairman:Seungjoon Oh

Mi-Kyung Kim Inje University, Korea	BS4The simple solution for injectable patients' compliance and glycemic control

Luncheon symposium 1 Sponsored by BI-LLY	12:30~14:00 / Friday 7 October Convention Hall A, 4F Chairman:Hyeong-Kyu Park

Mi Kyung Kim Keimyung University, Korea	LS1Management of CRM and role of SGLT2i in clinical practice: perspective

Luncheon symposium 2 Sponsored by Daewoong Pharmaceutical	12:30~14:00 / Friday 7 October Convention Hall B, 4F Chairman:Bon Jeong Ku

Young Min Cho Seoul National University, Korea	LS2Effects of patient-driven lifestyle modification using is-CGM in patients wirh type 2 diabetes

Luncheon symposium 3 Sponsored by Novo Nordisk	12:30~14:00 / Friday 7 October Convention Hall C, 4F Chairman:You-Cheol Hwang

Juris Meier Augusta Clinic Bochum, Germany	LS3The new wave of incretin therapy

Luncheon symposium 4 Sponsored by Chongkundang	12:30~14:00 / Friday 7 October Emerald Hall A, 3F Chairman:Jioh Mok

Gyuri Kim Sungkyunkwan University, Korea	LS4What's new; TZD in Korea?

Luncheon symposium 5 Sponsored by AstraZeneca	12:20~13:30 / Saturday 8 October Convention Hall A, 4F Chairman:Min-Seon Kim

Mark Cooper Monash University, Australia	LS5Optimal clinical approach for the management of diabetes and chronic complications with SGLT2 inhibitors

Luncheon symposium 6 Sponsored by Handok	12:20~13:30 / Saturday 8 October Convention Hall B, 4F Chairman:Sungdae Moon

Sung Hee Choi Seoul National University, Korea	LS6The place of DPP4 inhibitors in type 2 diabetes therapeutics

Luncheon symposium 7 Sponsored by Dong-A ST	12:20~13:30 / Saturday 8 October Convention Hall C, 4F Chairman:In-Kyung Jeong

Sung Hoon Yu Hanyang University, Korea	LS7Efficacy and safety of evogliptin add on therapy to DAPA/MET combinations in poorly controlled patients with type 2 diabetes

Luncheon symposium 8 Sponsored by LG Chem	12:20~13:30 / Saturday 8 October Emerald Hall A, 3F Chairman:Young Jung Cho

Yun Kyung Cho University of Ulsan, Korea	LS8The combination of DPP-4 inhibitor plus SGLT-2 inhibitor as attractive treatment option: from rationale to clinical aspects

Korean Diabetes Association

(04146) 101-2104, Lotte Castle President, 109 Mapo-gu, Seoul, Korea

E-mail : icdm@diabetes.or.kr

Congress Secretariat (Planbear)

#1101, 220, Gonghang-daero, Gangseo-gu, Seoul (07806), Republic of Korea

TEL : +82-2-6734-1011/1012/1013
E-mail : icdm@diabetes.or.kr